Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med. 2022 Mar 3;386(9):847-860. doi: 10.1056/NEJMoa2117608. Epub 2022 Feb 9.
N Engl J Med. 2022.
PMID: 35139271
Free PMC article.
Clinical Trial.
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group.
Hardt K, et al.
Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13.
Lancet Infect Dis. 2022.
PMID: 36113538
Free PMC article.
Clinical Trial.
Item in Clipboard
Nickel-resistance-based minitransposons: new tools for genetic manipulation of environmental bacteria.
Taghavi S, Delanghe H, Lodewyckx C, Mergeay M, van der Lelie D.
Taghavi S, et al. Among authors: delanghe h.
Appl Environ Microbiol. 2001 Feb;67(2):1015-9. doi: 10.1128/AEM.67.2.1015-1019.2001.
Appl Environ Microbiol. 2001.
PMID: 11157282
Free PMC article.
Item in Clipboard
Cite
Cite